Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 15, 2013, Pages 1794-1813

  Mountziaris, Paschalia M ^a   Dennis Lehman, E ^a   Mountziaris, Ioannis ^a   Sing, David C ^a   Kurtis Kasper, F ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

bone tissue engineering; inflammation; mesenchymal stem cells; scaffold; tumor necrosis factor alpha

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BIODEGRADABLE POLYMER SCAFFOLDS; BONE TISSUE ENGINEERING; INFLAMMATION; MESENCHYMAL STEM CELL; OSTEOGENIC DIFFERENTIATION; PRO-INFLAMMATORY CYTOKINES; TUMOR NECROSIS FACTOR-ALPHA;

DEPOSITION; DESIGN; FLOWCHARTING; GLYCOPROTEINS; MACROPHAGES; PHOSPHATASES; SCAFFOLDS; SCAFFOLDS (BIOLOGY); THREE DIMENSIONAL;

CELL CULTURE;

ALKALINE PHOSPHATASE; DEXAMETHASONE; POLYCAPROLACTONE; POLYMER; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME INHIBITION; FRACTURE; HISTOLOGY; MALE; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; HISTOCYTOCHEMISTRY; MALE; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; POLYESTERS; RATS; RATS, INBRED F344; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884591014     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2013.803455     Document Type: Article

References (38)

1. Mountziaris PM, Spicer PP, Kasper FK, Mikos AG. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng. Part B Rev. 2011;17:393-402
2. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 2003;88:873-884
3. Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F, Duda GN. The early fracture hematoma and its potential role in fracture healing. Tissue Eng. Part B Rev. 2010;16:427-434
4. Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-Derived stromal cells. Proc. Natl. Acad. Sci. USA. 2011;108:1585-1590
5. Pape H-C, Marcucio R, Humphrey C, Colnot C, Knobe M, Harvey EJ. Trauma-induced inflammation and fracture healing. J. Orthop. Trauma. 2010;24:522-525
6. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 2009;5:667-676
7. Kon T, Cho T-J, Aizawa T, Yamazaki M, Nooh N, Graves DT, Gerstenfeld LC, Einhorn TA. Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegrin ligand) and related pro-inflammatory cytokines during fracture healing. J. Bone Miner. Res. 2001;16:1004-1014
8. Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng. Part B Rev. 2008;14:179-186
9. Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Tsay A, Fitch J, Barnes GL, Graves DT, Einhorn TA. Impaired fracture healing in the absence of TNF-α signaling: The role of TNF-α in endochondral cartilage resorption. J. Bone Miner. Res. 2003;18:1584-1592
10. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, Einhorn TA. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factoralpha signaling. Cells Tissues Organs. 2001;169:285-294
11. Bocker W, Docheva D, Prall W, Egea V, Pappou E, Rossmann O, Popov C, Mutschler W, Ries C, Schieker M. IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells. J. Mol. Med. 2008;86:1183-1192
12. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-{alpha}, LPS, or hypoxia produce growth factors by an NF{kappa}B-but not JNK-Dependent mechanism. Am. J. Physiol. Cell. Physiol. 2008;294: C675-C682
13. Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNF[alpha] promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-[kappa]B signaling pathway. Bone. 2009;45:367-376
14. Ding J, Ghali O, Lencel P, Broux O, Chauveau C, Devedjian JC, Hardouin P, Magne D. TNF-[alpha] and IL-1[beta] inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 2009;84:499-504
15. Paula-Silva FWG, Ghosh A, Silva LAB, Kapila YL. TNF-{alpha} promotes an odontoblastic phenotype in dental pulp cells. J. Dent. Res. 2009;88:339-344
16. Mountziaris PM, Tzouanas SN, Mikos AG. Dose effect of tumor necrosis factor-[alpha] on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. Biomaterials. 2010;31:1666-1675
17. Lacey DC, Simmons PJ, Graves SE, Hamilton JA. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: Implications for bone repair during inflammation. Osteoarthritis Cartilage. 2009;17:735-742
18. Lin C-C, Metters AT, Anseth KS. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNF[alpha]. Biomaterials. 2009;30:4907-4914
19. Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W. Tumor necrosis factor-Alpha: Alternative role as an inhibitor of osteoclast formation in vitro. Bone. 2006;39:325-335
20. Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA. 2006;103:14925-14930
21. Mountziaris PM, Tzouanas SN, Mikos AG. The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation of mesenchymal stem cells. J. Biomed. Mater. Res A. 2012;100A:1097-1106
22. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: A review. Tissue Eng. 2006;12:1197-1211
23. Pham QP, Sharma U, Mikos AG. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules. 2006;7:2796-2805
24. Datta N, Holtorf HL, Sikavitsas VI, Jansen JA, Mikos AG. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials. 2005;26:971-977
25. Pham QP, Kasper FK, Baggett LS, Raphael RM, Jansen JA, Mikos AG. The influence of the in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials. 2008;29:2729-2739
26. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-74
27. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997;64:295-312
28. Merchant FA, Periasamy A. Correction using calibration images. In: Wu Q, Merchant FA, Castleman KR, editors. Microscope Image Processing. Burlington (VT): Elsevier; 2008. 258
29. Lu Z, Wang G, Dunstan CR, Chen Y, Lu WY-R, Davies B, Zreiqat H. Activation and promotion of adipose tissue-Derived mesenchymal stem cells by tumour necrosis factor-Alpha preconditioning for bone tissue engineering. J Cell Physiol. 2013;228:1737-1744
30. Briolay A, Lencel P, Bessueille L, Caverzasio J, Buchet R, Magne D. Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-Alpha in human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2013;430:1072-1077
31. Lu Z, Wang G, Dunstan CR, Zreiqat H. Short-Term exposure to tumor necrosis factor-Alpha enables human osteoblasts to direct adipose tissue-Derived mesenchymal stem cells into osteogenic differentiation. Stem Cells Dev. 2012;21:2420-2429
32. Martins AM, Pham QP, Malafaya PB, Sousa RA, Gomes ME, Raphael RM, Kasper FK, Reis RL, Mikos AG. The role of lipase and a-Amylase in both the degradation of starch/poly (e-caprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. Tissue Eng. Part A. 2009;15:295-305
33. Yang W, Yang F, Wang Y, Both SK, Jansen JA. In vivo bone generation via the endochondral pathway on three-Dimensional electrospun fibers. Acta Biomater. 2013;9:4505-4512
34. Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-Ascorbic acid. J. Cell. Biochem. 1998;71:55-62
35. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994;134:277-286
36. Rundle CH, Wang H, Yu H, Chadwick RB, Davis EI, Wegedal JE, Lau K-HW, Mohan S, Ryaby JT, Baylink DJ. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone. 2006;38:521-529
37. Hecht J, Kuhl H, Haas SA, Bauer S, Poustka AJ, Lienau J, Schell H, Stiege AC, Seitz V, Reinhardt R, Duda GN, Mundolos S, Robinson PN. Gene identification and analysis of transcripts differentially regulated in fracture healing by EST sequencing in the domestic sheep. BMC Genomics. 2006;7:172
38. Singhatanadgit W, Salih V, Olsen I. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-[alpha] in human bone cells. Int. J. Biochem. Cell Biol. 2006;38(10):1794-1807